These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Successful use of rituximab in Evans syndrome and refractory immune thrombocytopenic purpura. Kashif M; Qureshi A; Adil SN; Khurshid M J Pak Med Assoc; 2010 Jan; 60(1):64-5. PubMed ID: 20055286 [TBL] [Abstract][Full Text] [Related]
7. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus. Olfat M; Silverman ED; Levy DM Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672 [TBL] [Abstract][Full Text] [Related]
8. Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome. Rodella E; Pacquola E; Bianchini E; Ramazzina E; Paolini R Blood Coagul Fibrinolysis; 2008 Jun; 19(4):315-8. PubMed ID: 18469554 [TBL] [Abstract][Full Text] [Related]
9. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients. Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR; Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390 [TBL] [Abstract][Full Text] [Related]
10. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. Peñalver FJ; Alvarez-Larrán A; Díez-Martin JL; Gallur L; Jarque I; Caballero D; Díaz-Mediavilla J; Bustelos R; Fernández-Aceñero MJ; Cabrera JR; Ann Hematol; 2010 Nov; 89(11):1073-80. PubMed ID: 20526716 [TBL] [Abstract][Full Text] [Related]
11. Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia. Heidel F; Lipka DB; von Auer C; Huber C; Scharrer I; Hess G Thromb Haemost; 2007 Feb; 97(2):228-33. PubMed ID: 17264951 [TBL] [Abstract][Full Text] [Related]
12. Rituximab in the treatment of autoimmune haematological disorders. Garvey B Br J Haematol; 2008 Apr; 141(2):149-69. PubMed ID: 18318765 [TBL] [Abstract][Full Text] [Related]
13. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation. Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab. Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults. Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540 [TBL] [Abstract][Full Text] [Related]
16. [Effective danazol therapy for a patient with Evans syndrome]. Koike M; Ishiyama T; Saito K; Osawa H; Hashimoto M; Wakabayashi Y; Tsuruoka N Rinsho Ketsueki; 1993 Feb; 34(2):143-6. PubMed ID: 8492411 [TBL] [Abstract][Full Text] [Related]
17. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis. Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J; Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322 [TBL] [Abstract][Full Text] [Related]
18. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ transplant recipients, report of five cases and review of the literature. Miloh T; Arnon R; Roman E; Hurlet A; Kerkar N; Wistinghausen B Pediatr Transplant; 2011 Dec; 15(8):870-8. PubMed ID: 22112003 [TBL] [Abstract][Full Text] [Related]
19. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome. Erdozain JG; Ruiz-Irastorza G; Egurbide MV; Aguirre C Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486 [TBL] [Abstract][Full Text] [Related]
20. Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP). Alasfoor K; Alrasheed M; Alsayegh F; Mousa SA Ann Hematol; 2009 Mar; 88(3):239-43. PubMed ID: 18704420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]